Person who experienced the adverse event (patient)
Event ID | CASE | I F COD | FOLL SEQ | IMAGE | EVENT DT | MFR DT | FDA DT | REPT COD | MFR NUM | MFR SNDR | AGE | AGE COD | GNDR COD | E SUB | WT | WT COD | REPT DT | OCCP COD | DEATH DT | TO MFR | CONFID | REPORTER COUNTRY |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
4627346 | 5734925 | F | 2 | 4627346-6 | 20050118 | 20050322 | 20050331 | EXP | 2005-00094 | MILLENNIUM PHARMACEUTICALS INC. | 72 | YR | F | N | 60 | KG | 20050329 | MD |
Drug(s) used by person
Event ID | DRUG SEQ | ROLE COD | DRUGNAME | VAL VBM | ROUTE | DOSE VBM | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM |
---|---|---|---|---|---|---|---|---|---|---|---|
4627346 | 1005848166 | PS | VELCADE | 1 | INTRAVENOUS | 2.10 MG, INTRAVENOUS | Y | D | 21602 | ||
4627346 | 1005871470 | C | HYDROMORPHONE | 2 | |||||||
4627346 | 1005871471 | C | AMLODIPINE | 1 | |||||||
4627346 | 1005871472 | C | ENALAPRIL | 2 | |||||||
4627346 | 1005871473 | C | PANTOPRAZOLE SODIUM | 1 | |||||||
4627346 | 1005871474 | C | SERTRALINE HCL | 1 | |||||||
4627346 | 1005871475 | C | TORSEMIDE | 1 | |||||||
4627346 | 1005871476 | C | URAPIDIL | 2 |
Indications of drugs used
Event ID | DRUG SEQ | INDI PT |
---|---|---|
4627346 | 1005848166 | MULTIPLE MYELOMA |
Outcome of event
Event ID | OUTC COD |
---|---|
4627346 | OT |
Reactions reported
Event ID | PT |
---|---|
4627346 | ABSCESS LIMB |
4627346 | FIBRIN |
4627346 | GRANULOCYTE COUNT INCREASED |
4627346 | INFLAMMATION |
4627346 | JOINT EFFUSION |
4627346 | LYMPHOCYTE PERCENTAGE DECREASED |
4627346 | METASTASIS |
4627346 | MONARTHRITIS |
4627346 | MUSCLE NECROSIS |
4627346 | NEUTROPHIL PERCENTAGE INCREASED |
4627346 | PAIN |
Reporting Sources (this data is often not reported and may therefore be missing here)
Event ID | RPSR COD |
---|---|
4627346 | FGN |
4627346 | HP |
4627346 | OTH |
Therapies reported
Event ID | DRUG SEQ | START DT | END DT | DUR | DUR COD |
---|---|---|---|---|---|
4627346 | 1005848166 | 20050110 | 20050117 |